G1 Therapeutics Inc (GTHX)
4.53
-0.15
(-3.21%)
USD |
NASDAQ |
May 17, 16:00
4.53
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Cash from Operations (Quarterly): -8.898M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.898M |
| December 31, 2023 | -12.79M |
| September 30, 2023 | -10.58M |
| June 30, 2023 | 14.08M |
| March 31, 2023 | -29.05M |
| December 31, 2022 | -30.63M |
| September 30, 2022 | -21.25M |
| June 30, 2022 | -38.56M |
| March 31, 2022 | -38.18M |
| December 31, 2021 | -34.66M |
| September 30, 2021 | -34.08M |
| June 30, 2021 | -36.49M |
| March 31, 2021 | -26.88M |
| December 31, 2020 | -31.51M |
| September 30, 2020 | 3.639M |
| June 30, 2020 | -28.85M |
| March 31, 2020 | -27.02M |
| Date | Value |
|---|---|
| December 31, 2019 | -30.01M |
| September 30, 2019 | -25.13M |
| June 30, 2019 | -22.89M |
| March 31, 2019 | -21.55M |
| December 31, 2018 | -21.23M |
| September 30, 2018 | -16.81M |
| June 30, 2018 | -18.16M |
| March 31, 2018 | -18.11M |
| December 31, 2017 | -14.75M |
| September 30, 2017 | -13.76M |
| June 30, 2017 | -12.74M |
| March 31, 2017 | -9.28M |
| December 31, 2016 | -9.21M |
| September 30, 2016 | -5.285M |
| June 30, 2016 | -5.355M |
| March 31, 2016 | -5.291M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-38.56M
Minimum
Jun 2022
14.08M
Maximum
Jun 2023
-23.49M
Average
-27.94M
Median
Cash from Operations (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.70M |
| Geron Corp | -62.25M |
| Palatin Technologies Inc | -10.48M |
| Oragenics Inc | -1.102M |
| TG Therapeutics Inc | -8.207M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 5.289M |
| Cash from Financing (Quarterly) | -8.722M |
| Free Cash Flow | -18.18M |
| Free Cash Flow Per Share (Quarterly) | -0.1706 |
| Free Cash Flow to Equity (Quarterly) | -0.434M |
| Free Cash Flow to Firm (Quarterly) | -7.201M |
| Free Cash Flow Yield | -7.40% |